Jennifer Cochran and Amato Giaccia led a team of researchers who have developed an experimental therapy to treat metastatic cancer. (Photo: Rod Searcey)
Experimental therapy stopped the metastasis of breast and ovarian cancers in lab mice, pointing toward a safe and effective alternative to chemotherapy.
A team of Stanford researchers has developed a protein therapy that disrupts the process that causes cancer cells to break away from original tumor sites, travel through the bloodstream and start aggressive new growths elsewhere in the body.
This process, known as metastasis, can cause cancer to spread with deadly effect.
“The majority of patients who succumb to cancer fall prey to metastatic forms of the disease,” said Jennifer Cochran, an associate professor of bioengineering who describes a new therapeutic approach in Nature Chemical Biology.
Today doctors try to slow or stop metastasis with chemotherapy, but these treatments are unfortunately not very effective and have severe side effects.
The Stanford team seeks to stop metastasis, without side effects, by preventing two proteins – Axl and Gas6 – from interacting to initiate the spread of cancer.
Axl proteins stand like bristles on the surface of cancer cells, poised to receive biochemical signals from Gas6 proteins.
When two Gas6 proteins link with two Axls, the signals that are generated enable cancer cells to leave the original tumor site, migrate to other parts of the body and form new cancer nodules.
To stop this process Cochran used protein engineering to create a harmless version of Axl that acts like a decoy. This decoy Axl latches on to Gas6 proteins in the bloodstream and prevents them from linking with and activating the Axls present on cancer cells.
In collaboration with Professor Amato Giaccia, who leads the Radiation Biology Program in the Stanford Cancer Center, the researchers gave intravenous treatments of this bioengineered decoy protein to mice with aggressive breast and ovarian cancers.
Mice in the breast cancer treatment group had 78 percent fewer metastatic nodules than untreated mice. Mice with ovarian cancer had a 90 percent reduction in metastatic nodules when treated with the engineered decoy protein.
“This is a very promising therapy that appears to be effective and nontoxic in preclinical experiments,” Giaccia said. “It could open up a new approach to cancer treatment.”
The Latest on: Alternative to chemotherapy
via Google News
The Latest on: Alternative to chemotherapy
- Drive set to ‘fill freezer’ for cancer patientson December 1, 2019 at 10:01 am
He went through a long list of prepackaged food and shortened it with healthy alternatives, Lennartson said. “One of the things he says is to have people bring frozen fruit like mango chunks and ...
- Advanced 3D Prostate Treatment Acclaimed As The Best Prostate Cancer Treatment For Worldwide Male Populationon November 29, 2019 at 9:35 am
On the other hand, this alternative prostate therapy has a success rate of 95% ... There are many patients who have been benefited from Dr. Song’s prostate cancer treatment. The spokesperson states ...
- Metastatic Breast Cancer Treatment Market Is Expected to Reach USD 26,054.0 Million by 2025, at a CAGR of 9.40% Between 2019 to 2025on November 27, 2019 at 9:48 am
There is an extensive range of treatment alternatives for metastatic breast cancer, and new medicines are being assessed daily. Prevailing Exposure to Ionizing and Poor Diagnosis Gives Hike to ...
- Local artist needs alternative cancer treatment; raising $33,000on November 26, 2019 at 8:43 am
Local Artist Lisa Turner Holmes is trying to raise $33,000 in hopes of being able to afford alternative cancer treatment in Tijuana, Mexico. Holmes previously worked on artwork around the area, ...
- Hormonal Used in Place of Chemotherapy for Ectopic Pregnancyon November 25, 2019 at 12:37 pm
In contrast to methotrexate, letrozole works hormonally, "so this is potentially a huge breakthrough, in that you wouldn't need a chemotherapy regimen to treat an ectopic pregnancy ... "Methotrexate ...
- Prestigious NY Cancer Center Will Spend $3.7M To Study Bogus Cancer Treatmenton November 25, 2019 at 4:43 am
They found that "Patients who received complementary medicine were more likely to refuse other conventional cancer treatment, and had a higher risk of death than no complementary medicine." And also ...
- Fairfax cannabidiol sellers strive to weed out myth from scienceon November 22, 2019 at 12:57 pm
While doctors offered various prescriptions to alleviate her issues, Collingwood already had to take a maintenance drug as part of her cancer treatment and did not want to end up drowning in ...
- Tauranga mother dying of cancer resorts to alternative treatment in Mexicoon November 22, 2019 at 8:21 am
These are the desperate words of a Tauranga mother with terminal metastatic breast cancer who is flying to Mexico to undergo an alternative treatment in ... After going through chemotherapy, ...
- Hope4Cancer™ Treatment Centers To Launch 'Eight Days' The First Reality Show About Alternative Ways To Fight Canceron November 20, 2019 at 3:00 am
"We partnered with film producer, Charles Mattocks, to help us share our patients' stories, because we know of his work as a health advocate and appreciate his passion for investigative storytelling," ...
- New technology may offer alternative means of profiling tissueson November 19, 2019 at 10:30 am
Current cancer treatment courses often begin with tissue biopsies ... from Tel Aviv University (TAU), Herzliya Interdisciplinary (IDC), and Technion-Israel Institute of Technology may soon offer an ...
via Bing News